Skip to main content

Stroke Research

The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.

In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.

The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.

Projects

RES-Q PLUS: Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality

IP: Carlos Molina Cateriano
Collaborators: Noelia Rodríguez Villatoro, Federica Rizzo, David Rodriguez Luna, Carole Conforti
Funding agency: EUROPEAN COMMISSION
Funding: 396730
Reference: RES-Q PLUS_HE-HLTH-TOOL21
Duration: 01/11/2022 - 31/10/2026

Red Federada Para Acelerar La Aplicación De La Inteligencia Artificial En El Sistema Sanitario Español (TARTAGLIA)

IP: Anna Santamaria Margalef
Collaborators: Joan Morote Robles, Olga Méndez Fernández, Giorgio Colangelo, Olga Méndez Fernández, Olga Méndez Fernández, Olga Méndez Fernández, Olga Méndez Fernández, Olga Méndez Fernández
Funding agency: Ministerio de Asuntos Económicos y Transf Digital
Funding: 703098.75
Reference: MIA.2021.M02.0005_SANTAMARIA
Duration: 01/10/2021 - 31/12/2024

Logotip del Ministeri d'Assumptes Econòmics i Transformació Digital

Publications

Risk assessment of long-term epilepsy after de novo status epilepticus with clinical and electroencephalographic biomarkers: The AFTER score.

PMID: 37995538
Journal: EPILEPSY & BEHAVIOR
Year: 2023
Reference: Epilepsy Behav. 2023 Nov 22;149:109531. doi: 10.1016/j.yebeh.2023.109531.
Impact factor:
Publication type: Paper in international publication
Authors: Abraira, Laura; Adic, Filip; Adic, Nada Cemerlic; Aurelian, Rosca; Becker, David; Benedek, Imre; Benedek, Theodora; Berry, Colin; Birtolo, Lucia Ilaria; Bosserdt, Maria et al.
DOI: 10.1016/j.yebeh.2023.109531

The Influence of the Exposome in the Cutaneous Squamous Cell Carcinoma, a Multicenter Case-Control Study.

PMID: 38001636
Journal: Cancers
Year: 2023
Reference: Cancers (Basel). 2023 Nov 12;15(22):5376. doi: 10.3390/cancers15225376.
Impact factor:
Publication type: Paper in international publication
Authors: Abadias-Granado, Isabel; Abraira, Laura; Almagro, Manuel; Almenara-Blasco, Manuel; Arias-Santiago, Salvador; Banuls, Jose; Buendia-Eisman, Agustin; Campos-Fernandez, Daniel; Colmenero, Maria; De la Fuente-Meira, Sonia et al.
DOI: 10.3390/cancers15225376

Safety Outcomes of Antiplatelet Therapy During Endovascular Treatment of Tandem Lesions in Acute Ischemic Stroke Patients.

PMID: 38017258
Journal: Translational Stroke Research
Year: 2023
Reference: Transl Stroke Res. 2023 Nov 29. doi: 10.1007/s12975-023-01214-9.
Impact factor:
Publication type: Paper in international publication
Authors: Abdalkader, Mohamad; Abraham, Michael; Barkley, Tiffany; Barro, V; De Leacy, Reade; Divani, Afshin A; Farooqui, Mudassir; Fifi, Johanna; Galecio-Castillo, Milagros; Gonzalez-Morgado, D et al.
DOI: 10.1007/s12975-023-01214-9

Endovascular Therapy for Acute Stroke: New Evidence and Indications.

PMID: 38025253
Journal:
Year: 2023
Reference: J Neuroendovasc Ther. 2023;17(11):232-242. doi: 10.5797/jnet.ra.2023-0047. Epub 2023 Aug 29.
Impact factor:
Publication type: Paper in international publication
Authors: Abdalkader, Mohamad; Abdalkader, Mohamad; Abraham, Michael; Barkley, Tiffany; Bui, Jenny; de Havenon, Adam; De Leacy, Reade; Diana, Francesco; Divani, Afshin A; Farooqui, Mudassir et al.
DOI: 10.5797/jnet.ra.2023-0047

Blog

News

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.